Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for banking industry professionals · Friday, March 29, 2024 · 699,693,994 Articles · 3+ Million Readers

Global Acromegaly Treatment Market Will Reach USD 839.0 Million by 2022: Zion Market Research

According to the report, global acromegaly treatment market was valued at approximately USD 665.0 Million in 2016 and is expected to generate revenue of around USD 839.0 Million by the end of 2022, growing at a CAGR of around 3.95% between 2017 and 2022.

Sarasota, FL, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Acromegaly Treatment Market by Disease Type (Ectopic Acromegaly and Pseudo Acromegaly), By Diagnosis Type (Medical Imaging and Medical Laboratory Test) and By Treatment Type (Drug Therapy, surgery and Radiation Therapy) : Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022”. According to the report, global acromegaly treatment market was valued at approximately USD 665.0 Million in 2016 and is expected to generate revenue of around USD 839.0 Million by the end of 2022, growing at a CAGR of around 3.95% between 2017 and 2022.

Acromegaly is pituitary gland associated endocrine disorder caused by an increased level of growth hormone due to the tumor which leads to the abnormal growth of body and organs. There are various symptoms experienced by the patient like the protruded jaw, increased the size of limbs, the spacing between teeth of lower jaw and others. Conditions like hypertension, diabetes, enlarged heart, kidney failure, arthritis, and carpal tunnel syndrome worsen the condition of the patient. It is proved that in 90% acromegaly cases patient dies due to heart failure. This has increased the demand for better treatment options to cure the disease and increase the life expectancy for the patients of acromegaly. In most of the patients, surgical removal of pituitary gland reduces the level of growth hormones. But in some cases, if the tumor is not completely removed then, the patient has to undergo different sessions of radiation therapy to destroy the tumor cells completely. This disorder is primarily diagnosed by various symptoms and test like medical imaging and laboratory test for measuring glucose level, GH levels, and IGF-I levels are used to confirm the presence of the disease.

Browse through 90 Tables & 20 Figures spread over 110 Pages and in-depth TOC on "Global Acromegaly Treatment Market, 2016 – 2022: By Type, Share, Trends and Forecast Report”.

Request Free Sample copy of Global Acromegaly Treatment Market Report @ https://www.zionmarketresearch.com/sample/acromegaly-treatment-market

Factors driving the global acromegaly treatment market are high unmet needs in the developing countries and increased epidemiology for the disease due to increase in the tumor cases. Other major driving factors are an increase in the awareness about the disease and research & development for drug discovery to find the permanent cure for this disease. Several companies are investing time and money in R&D and clinical trials to develop the drug for treatment with permanent cure such as Ipsen, Novartis AG, and Pfizer Inc. Few drugs are in phases of clinical trials are expected to launch in the market after successful completion of a clinical trial such as BIM23B065 which is in clinical trial phase 2 and somatuline are in phase 3. Surgery and radiation therapies such as conventional radiation therapy and proton beam therapy have proved to be a helpful technique for the treatment of acromegaly.

North America represents developed regional markets for acromegaly and is expecting a significant growth in near future. The U.S. is leading the acromegaly treatment market by country in North America region. The U.S. market is expected to grow at the highest CAGR during the forecast period. This growth is mainly due to ongoing research and development for drug discovery, increase in the epidemiology of the disease, increase in the pituitary tumor cases, high disposable income and favorable reimbursement policies in the region. These factors are expected to support the growth of acromegaly treatment market over the forecast period in the North American region.

Browse the full " Acromegaly Treatment Market by Disease type (Ectopic Acromegaly and Pseudo Acromegaly), Diagnosis Type include Medical Imaging and Medical Laboratory Test and Treatment Type include Medication, surgery, and Radiation Therapy: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 – 2022" report at  https://www.zionmarketresearch.com/report/acromegaly-treatment-market

Europe is the second largest region in acromegaly treatment market and expected to show significant growth due to increase in research and development for drug discovery and high disposable income. Moreover better healthcare government policies for the treatment of acromegaly are also likely to boost the treatment market for acromegaly in Europe over the forecast period.

The Asia Pacific is a third largest region in the acromegaly treatment market and is expected to grow moderately over the forecast period due to the presence of emerging economies such as Japan, China, and India. The Increase in awareness about the disease is expected to support the growth of acromegaly treatment market over the forecast period. At the same time, stringent government policies and a medical scheme such as providing subsidized drugs and reimbursement in the developing countries of Asia Pacific is likely to slow down the rate of treatment in the region over the forecast period.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/acromegaly-treatment-market

The Middle East & Africa and Latin America are expected to experience a slow growth due to lack of awareness, and high treatment cost. These are the factors affecting the growth of acromegaly treatment market in the regions over the forecast period.

Some of the key players in acromegaly treatment market include Pfizer Inc., Chiasma Inc., Novartis AG, Ipsen Biopharmaceuticals Inc., Wockhardt Ltd., Troikaa Pharmaceuticals Limited, VHB Life Sciences Limited, GlaxoSmithKline plc and few others.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/2507


This report segments the Global Acromegaly Treatment Market as follows:

Global Acromegaly Treatment Market: Disease Type Segment Analysis

  • Ectopic Acromegaly
  • Pseudo Acromegaly

Global Acromegaly Treatment Market: Diagnosis Type Segment Analysis

  • Medical Imaging
  • Medical Laboratory Test

Global Acromegaly Treatment Market: Treatment Type Analysis

  • Surgery
  • Drug Therapy
  • Radiation Therapy

Global Acromegaly Treatment Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

For media inquiry contact our sales team @ sales@zionmarketresearch.com

Related Reports:

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter: https://twitter.com/zion_research

                    Contact Us:
                    
                    Joel John
                    
                    4283, Express Lane, Suite 634-143,
                    Sarasota, Florida 34249, United States
                    Tel: +49-322 210 92714
                    USA/Canada Toll-Free No.1-855-465-4651
                    Email: sales@zionmarketresearch.com
                    Website: https://www.zionmarketresearch.com

Primary Logo

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release